Convite SBMN - Medicina Nuclear em Cardiologia

Computer-assisted delineation of lung tumor regions in treatment planning CT images with PET/CT image sets based on an optimum contour selection method.

J Radiat Res. 2014 Jun 30. pii: rru056. [Epub ahead of print]

Jin Z¹, Arimura H², Shioyama Y³, Nakamura K⁴, Kuwazuru J⁵, Magome T¹, Yabu-Uchi H⁶, Honda H⁴, Hirata H⁶, Sasaki M⁶.

• ¹Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
• ²Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan arimurah@med.kyushu-u.ac.jp.
• ³Department of Heavy Particle Therapy and Radiation Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
• ⁴Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
• ⁵Medipolis Proton Therapy and Research Center, Higashikata, Ibusuki-shi, Kagoshima, Japan.
• ⁶Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

 

Abstract

To assist radiation oncologists in the delineation of tumor regions during treatment planning for lung cancer, we have proposed an automated contouring algorithm based on an optimum contour selection (OCS) method for treatment planning computed tomography (CT) images with positron emission tomography (PET)/CT images. The basic concept of the OCS is to select a global optimum object contour based on multiple active delineations with a level set method around tumors. First, the PET images were registered to the planning CT images by using affine transformation matrices. The initial gross tumor volume (GTV) of each lung tumor was identified by thresholding the PET image at a certain standardized uptake value, and then each initial GTV location was corrected in the region of interest of the planning CT image. Finally, the contours of final GTV regions were determined in the planning CT images by using the OCS. The proposed method was evaluated by testing six cases with a Dice similarity coefficient (DSC), which denoted the degree of region similarity between the GTVs contoured by radiation oncologists and the proposed method. The average three-dimensional DSC for the six cases was 0.78 by the proposed method, but only 0.34 by a conventional method based on a simple level set method. The proposed method may be helpful for treatment planners in contouring the GTV regions.
© The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

KEYWORDS:

PET/CT images; computer-assisted delineation; gross tumor volume (GTV); level set method; lung tumor

PMID: 24980022 [PubMed - as supplied by publisher] 

 

Free full text

Presurgical SPECT/CT shows more cancer than current standard

Date:

June 9, 2014

Source:

Society of Nuclear Medicine

Summary:

Sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography and computed tomography than with another molecular imaging technique called lymphoscintigraphy. This has been demonstrated through startling data from an international multi-center trial focused on melanoma, breast carcinoma, and malignancies of the pelvis, such as prostate and cervical cancer.

Startling data from an international multi-center trial provide growing evidence that sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography and computed tomography (SPECT/CT) than with another molecular imaging technique called lymphoscintigraphy. This conclusion held after imaging a range of cancers displaying a variety of lymphatic drainage types associated with melanoma, an aggressive skin cancer; breast carcinoma; and malignancies of the pelvis, such as prostate and cervical cancer, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

Lymph node imaging is an essential tool in the context of surgical resection, because cancer spreads first to the lymph nodes, specifically the sentinel lymph nodes, before navigating the bloodstream and developing new malignancies elsewhere in the body. Molecular imaging of these sentinel nodes provides a surgical map that can improve a patient's chances of becoming cancer free.

"We found significantly more sentinel lymph node involvement with SPECT/CT, which altered surgical planning for many of our patients -- a finding that was repeated across all malignancies and clinical institutions," said Thomas N.B. Pascual, MD, co-author of the study and a research scientist from the section of nuclear medicine and diagnostic imaging and division of human health of the International Atomic Energy Agency in Vienna, Austria. "These results could potentially inform new clinical practice and shape appropriate use of SPECT/CT imaging for patients selected for surgery."

Study findings showed that SPECT/CT breast cancer imaging caught 13 percent more cancerous sentinel nodes -- 2,165 nodes versus 1,892 using planar lymphoscintigraphy. The hybrid SPECT system also caught 11.5 percent more sentinel nodes when imaging for melanoma, with 602 versus 532 nodes detected. In addition, 29.2 percent more nodes were imaged using SPECT/CT to detect pelvic cancer -- 195 nodes found versus 138 with planar imaging.

Changes in surgical planning as dictated by SPECT/CT were substantial -- 16.9 percent of breast cancer surgeries underwent a change in management, 37 percent of surgeries for melanoma changed and 64.1 percent of surgical plans for pelvic cancer were changed due to detection of additional sentinel nodes. Calculated mismatch between sentinel nodes and lymphatic territories using the two imaging systems was gauged at 17 percent for breast carcinoma, 11.2 percent for melanoma and 50 percent for pelvic imaging. The significantly higher mismatch in pelvic tumors was thought to be due to relatively deeper lymphatic drainage and location of pelvic sentinel nodes.

Cancers are a leading cause of death. The most recent data available shows that cancers were the cause of 8.2 million deaths worldwide in 2012, according to the World Health Organization. Annual cancer diagnoses are expected to increase more than 60 percent from 14 million in 2012 to 22 million within the next two decades. Lung, liver, stomach, colorectal and breast cancers cause the most cancer deaths each year.

Link original: http://www.sciencedaily.com/releases/2014/06/140609140901.htm

Diez años de medicina nuclear

A diaro pasan por esta sección entre 25 y 35 pacientes El Hospital de Torrecárdenas dispone de dos equipos de gammacámara

El responsable de la sección de medicina nuclear del Complejo Hospitalario Torrecárdenas.

Imagen de una de las pruebas realizadas.

Fue en febrero del año 2004 cuando el Complejo Hospitalario Torrecárdenas inauguraba la Unidad de Medicina Nuclear. Un área que cumple una década al servicio de los ciudadanos de toda la provincia y a la que llegó el primer equipo de gammacámara tres años después. El actual jefe de la sección de Medicina Nuclear, Manuel Guerrero, ha informado de que diariamente pasan por esta área hospitalaria entre 25 y 35 personas, lo que supone entre 4.500 y 5.000 pacientes anuales. Todos estos pacientes llegan a medicina nuclear derivados de otras especialidades, especialmente de pediatría, nefrología, oncología y cardiología. La medicina nuclear es una especialidad de la medicina actual. En la misma se utilizan radiotrazadores o radiofármacos, que están formados por un medicamento transportador y un isótopo radiactivo. Estos radiofármacos se aplican dentro del organismo humano por diversas vías (la más utilizada es la vía intravenosa). Una vez que el radiofármaco está dentro del organismo, se distribuye por diversos órganos dependiendo del tipo de radiofármaco empleado. La distribución del radiofármaco es detectado por un aparato detector de radiación llamado gammacámara y almacenado digitalmente. Luego se procesa la información obteniendo imágenes de todo el cuerpo o del órgano en estudio. Estas imágenes, a diferencia de la mayoría de las obtenidas en radiología, son imágenes funcionales y moleculares, es decir, muestran como están funcionando los órganos y tejidos explorados o revelan alteraciones de los mismos a un nivel molecular. Por lo general, las exploraciones de medicina nuclear no son invasivas y carecen de efectos adversos. Se utiliza para diagnosticar y determinar la gravedad y tratamiento de varias enfermedades, incluyendo cáncer en diversos tipos, enfermedades cardíacas, gastrointestinales, endocrinas, desórdenes neurológicos, y otras anomalías dentro del cuerpo. Debido a que los procedimientos de medicina nuclear pueden detectar actividades moleculares dentro del cuerpo, ofrecen la posibilidad de identificar enfermedades en sus etapas tempranas, así también como las respuestas inmediatas de los pacientes a las intervenciones terapéuticas. El Complejo Hospitalario Torrecárdenas amplió el servicio de medicina nuclear con la puesta en funcionamiento de una segunda gammacámara, lo que permitió atender a un 35% más de pacientes. En el año 2007 fueron 4.500 los pacientes explorados con la gammacámara que actualmente está en funcionamiento en el Complejo Hospitalario Torrecárdenas. Las gammacámaras son equipos diagnósticos indicados para analizar un gran número de procesos de tipo reumático, infecciosos, vasculares y degenerativos o la valoración funcional de determinados órganos, como el riñón, corazón, pulmón, hígado y aparato digestivo. 

Estos estudios son muy empleados y eficaces para el diagnóstico del cáncer, aunque también para valorar múltiples patologías benignas como fracturas óseas, infecciones, disfunciones del tiroides o embolias pulmonares, por citar algunas de las más comunes. También se utiliza para seguir la evolución de los pacientes que han sufrido un trasplante de riñón. El uso de este equipamiento tecnológico mejorará tanto la rapidez como la precisión en los diagnósticos a pacientes de medicina nuclear, ya que la fusión de imágenes obtenidas con la gammacámara y el TAC mejora mucho su calidad.

Link original: http://www.elalmeria.es/article/almeria/1810450/diez/anos/medicina/nuclear.html

ASNC2014: Early-Bird Closes July 21 – Register Now!

Don't miss ASNC's 19th Annual Scientific Session "ASNC2014" in Boston, MA -- September 18 - 21, 2014. This exciting 4-day educational event will provide sessions on emerging nuclear cardiology research, technology, advances in treatment, performance standards, cardiac PET and SPECT imaging, and much more.

Early Bird Deadline is July 21!

Make your travel arrangements, book your hotel, and register by July 21, 2014 to receive the Early-Bird rate for the ASNC2014 Annual Meeting. Don’t miss this important conference that presents emerging research, valuable contacts and resources, new technology and advances in treatment, healthcare updates, and much more!

Register Now

Early Bird ends 7/21/14 

ASNC2014 will provide educational tracks for all levels of expertise and seniority. This must-attend event supports a multimodality agenda featuring a collaborative educational and research effort across many imaging disciplines to help promote a cost-effective, patient-centered approach to medical care.

Attendees will have opportunities to network with nuclear cardiology professionals, contribute to programs that promote innovation and quality in cardiology imaging; and display their latest products at this meeting through advertising, exhibiting, commercial support and educational grants. Program highlights include:

• NEW FOR 2014 -- Maintenance of Certification (MOC) sessions available with audience response capabilities. Attend the session and then complete the test for 10 points each. Attendees must be registered with ABIM to obtain MOC points.
  • 2014 Update in Cardiovascular Disease module from the American Board of Internal Medicine (ABIM).
  • 
    
  • A nuclear cardiology specific module (2014 American Society of Nuclear Cardiology MOC Module 1), submitted to ABIM for approval for an additional 10 MOC points.
     
• Case-based Ethics lunch session -- following each case presented by junior faculty, a panel of experts and ethicists will discuss and provide opinions on the case.
   
• International research presentations showcasing the best work from around the world. 
   
• Policy and practice sessions co-sponsored by MedAxiom will discuss the impact of the changing health care environment and offer opportunities for discussion with experts.
   
• Numerous case-based sessions focused on concepts fundamental to the practice of nuclear cardiology, and expert panel discussions on cases submitted by fellows. 
   
• Posters that will be available for review throughout the duration of the meeting.

Make your travel arrangements, book your hotel and register now to receive the Early-Bird rate 

by July 21, 2014 for ASNC2014!

Related Items:

• ASNC2014 Online Program Planner: Plan Your ASNC2014 Itinerary now

SBMN na TV

Carlyle Barral, coord. do Departamento de Comunicação da SBMN, esteve presente no programa "De tudo um pouco" da Rede Super de Televisão. Assista a entrevista na íntegra aqui!

Edição 80 do Interação Diagnóstica já em circulação

O Jornal Interação Diagnóstica de junho/julho já foi distribuído aos 12 mil nomes do nosso mailing, em todo o Brasil.

Nesta edição, há uma entrevista com a Dra. Valerie Jackson, especialista de mama dos Estados Unidos, sobre gestão de pessoas difíceis no ambiente de trabalho, tema de aula que proferiu na JPR’2014.

Há, ainda, uma entrevista com o Dr. Ênis Donizetti Silva, presidente da Sociedade de Anestesiologia do Estado de São Paulo, sobre procedimentos invasivos com visualização à beira-leito. Já o Dr. Mauricio Castillo, da Universidade da Carolina do Norte, oferece sua visão sobre a importância da medicina personalizada para os diagnósticos em neurorradiologia.

Veja também como foi a inauguração da primeira fábrica de arcos cirúrgicos do Brasil, que a alemã Ziehm passa a produzir em parceria com a Sul Imagem.

Não recebe o Jornal ID impresso? Mudou de endereço? Cadastre-se ou mantenha seus dados atualizados para recebê-lo gratuitamente e se manter bem informado sobre a área de diagnóstico por imagem. Escreva para comercial@interacaodiagnostica.com.br.

A partir de 15 de julho, confira a edição na íntegra no aplicativo do ID – baixe agora, para celular ou tablet, Android ou iOS.

Link original: http://www.interacaoexpress.com.br/edicao-80-do-interacao-diagnostica-ja-em-circulacao/

Encontro de Discussão de Casos em 11/08/2014

A SBMN promoverá um encontro dia 11/08/2014 no Hotel Golden Tulip da Alameda Santos, às 20hs e como tema, Discussão de Casos Interessantes de Medicina Nuclear em Cardiologia.

 

Cada equipe USP, UNICAMP e BARRETOS apresentará  1 caso interessante que será discutido com os participantes, sob a coordenação do Dr José Soares Junior, Médico Nuclear do INCOR, SP.

 

20:15 - Início

20:15 - Apresentação da 1a Equipe

20:30 - Discussão

20:40 - Apresentação da 2a Equipe

20:55 - Discussão

21:05 - Apresentação da 3a Equipe

21:20 - Discussão

21:30 - Confraternização

 

As Vagas são limitadas, faça sua inscrição no site da SBMN!

Case of the Month - July 2014

 

Analyzing DXA’s with Soft Tissue Artifacts - Part II

Submitted by Maureen Costello, RT, CBDT. Division of Endocrinology, University of Chicago Medical Center.

Sixty-nine year old post natural menopause black female, without personal or family history of prior fractures. She is hypothyroid currently on replacement with normal TSH, and a history of lung cancer in remission for +10 yrs. The patient was properly gowned and gave no history of abdominal surgery or recent contrast studies, that could explain the present of this dense mass in the left lower quadrant. Addition imaging if clinically indicated was suggested in the final DXA report, but the findings or a definite etiology of this mass were not available at the date of this submission.
QUESTION

• Would you accept the current analysis of this lumbar spine scan?
• Was the calcified mass in the left lower quadrant adjacent to L3 properly identified by the software and excluded from the soft tissue baseline calculations? How can you tell?

 

Case answers & Discussion

 

Inscrições para o Prêmio de Incentivo em C&T para o SUS vão até dia 11

Agência FAPESP – Estão abertas, até 11 de julho, as inscrições para o Prêmio de Incentivo em Ciência e Tecnologia para o SUS, promovido pelo Ministério da Saúde.

De acordo com os organizadores, a iniciativa “busca valorizar os pesquisadores e suas pesquisas, indispensáveis para o desenvolvimento das políticas públicas de saúde no país”.

Os candidatos podem concorrer em quatro categorias: tese de doutorado (premiação no valor de R$ 50 mil), dissertação de mestrado (R$ 30 mil), trabalho científico publicado (R$ 50 mil) e monografia de especialização ou residência (R$ 15 mil).

O prêmio é concedido pelo Ministério da Saúde desde 2002 e está em sua 13ª edição. Os candidatos devem ter publicado artigos ou ter tido seus trabalhos aprovados entre 10 de junho de 2013 e 26 de maio de 2014.

As inscrições para a primeira fase do prêmio podem ser feitas pela internet no endereço eletrônico http://www.saude.gov.br/premio até as 18h (horário de Brasília) do dia 11 de julho.

Na primeira fase, cada resumo de trabalho será avaliado por dois especialistas convidados. Serão classificados para a segunda fase de avaliação os 20 melhores resumos em cada uma das quatro categorias. Os trabalhos selecionados para a segunda fase serão divulgados até 25 de agosto no endereço eletrônico http://www.saude.gov.br/sctie.

Uma comissão julgadora avaliará a íntegra dos trabalhos previamente selecionados. A cerimônia de premiação será realizada até 31 de dezembro de 2014, em Brasília. Um livro será publicado contendo os resumos dos trabalhos vencedores e dos que receberem menções honrosas.

Mais informações: http://portal2.saude.gov.br/sisct/login.cfm

Link original: http://agencia.fapesp.br/19340

2014 SNMMI Annual Meeting highlights research and looks to future

Premier nuclear and molecular imaging conference draws thousands from across the globe

Reston, Va. (June 30, 2014) — Top research from around the world and the latest advances in technology were brought together for the 2014 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in St. Louis, Mo., June 7-11. The meeting welcomed more than 5,700 physicians, technologists, physicists, scientists and exhibitors for an in-depth review of molecular imaging technologies, clinical applications, and translational and advanced research topics. 

This year's meeting offered more than 100 scientific sessions, close to 750 oral presentations and more than 1,155 posters displayed in the poster hall. Educational courses covered topics including dose optimization, multimodality imaging, targeted radioisotope therapies, imaging in infection and inflammation and the status of DOTA agents. In the exhibit hall, more than150 companies showcased the latest in nuclear medicine and molecular imaging technology.

A highlight of the meeting was the SNMMI plenary session on Sunday, June 8, where lymphoma survivor, award-winning author and NBC news correspondent Jonathan Alter presented the Henry N. Wagner, Jr. Lectureship on "The Future of Patient-Centered Medicine." On Monday, June 9, Barry A. Siegel, MD, professor of radiology and medicine and chief of the Division of Nuclear Medicine at Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, received the 2014 Benedict Cassen Prize for research in nuclear medicine and presented a lecture titled, "What Have We Learned from the National Oncologic PET Registry?"

SNMMI's 2014 Image of the Year was chosen from an abstract presented by Nobuyuki Okamura, MD, PhD, of Tohoku University School of Medicine and his colleagues. The image—a PET image using a novel tracer, F-18 THK5117—demonstrated differential distributions of amyloid tracer versus tau/neurofibrillary tangle tracer in Alzheimer patients. This research sheds critical light on the pathology of Alzheimer's disease, which could help develop better diagnostic methods and effective treatments.

Also at the meeting, SNMMI held its fourth annual Patient Program, where more than 100 patients and caregivers attended sessions on advances in nuclear medicine and molecular imaging. Topics featured included colorectal cancer, prostate cancer, thyroid cancer and neuroendocrine tumors.

The 2015 SNMMI Annual Meeting heads to Baltimore, Md., June 6-10, 2015. For more information, visit http://www.snmmi.org. 

Link original: http://www.eurekalert.org/pub_releases/2014-06/sonm-2sa063014.php

Last Chance to Register for July ASNC Board Prep!

 

ASNC is pleased to offer the Nuclear Cardiology Board Exam Preparation Course in Chicago, IL on July 11-13, 2014. The Nuclear Cardiology Board Exam Preparation Course is a comprehensive course in nuclear cardiology designed to help you prepare for the certification and recertification exam in nuclear cardiology, as well as assist you in achieving core competencies in nuclear cardiology. Physicians interested in a broad review of nuclear cardiology are also encouraged to attend. 

Prepare for the Board Exam, register now.
To view the agenda, click here.

Course objectives include:

• Appraise knowledge of physics and instrumentation associated with nuclear imaging
• Outline the rationale for stress perfusion imaging and the use of new pharmacologic tracers
• Select patients for nuclear cardiology procedures based on Appropriate Use Criteria
• Describe radiation reduction methods in nuclear cardiology, including instrumentation, software and lower radiation imaging protocols
• Compare and contrast the strengths and weaknesses of other nuclear cardiac imaging procedures and how they can be most effectively incorporated
• Describe the role of multimodality imaging to enhance patient care
• Review and improve interpretation skills in standard and emerging technologies in nuclear cardiology

The course is also designed as an interactive program with panel discussions presented by a renowned nuclear cardiology faculty.

REGISTER NOW 

Can't make July? Join us for Board Prep in September!

Related Items:

• ASNC2014: Boston, register now.
• ASNC Membership: Become a member.

 

Join ASNC, Get Discounted Rates to Our Educational Programs!

 

Become an ASNC Member,
Get a Discounted Rate for ASNC2014

The American Society of Nuclear Cardiology (ASNC), provides members with premiere education, advocacy, resources and guidelines to its growing membership of over 4,600 imaging professionals worldwide. ASNC’s commitment to its members and their patients has positioned the Society as a leader in quality assurance within the nuclear cardiovascular community.

When you're an ASNC member, the difference between member and non-membership are the savings you incur off many of our educational programs and products. Join ASNC now and receive a discounted registration to ASNC2014, The 19th Annual Scientific Session of the American Society of Nuclear Cardiology, on September 18-21 in Boston, MA – nuclear cardiology’s premier conference highlighting emerging technologies, professional standards of care and challenging case studies.

Become a member today and receive the many benefits and discounts membership has to
offer, click here.

Additional membership savings include: 

• Nuclear Cardiology Board Exam Prep: July 11-13 in Chicago, IL or September 17-18
  in Boston, MA
• Journal of Nuclear Cardiology (JNC): ASNC members receive a complimentary subscription
  to JNC, complete with peer-reviewed original articles and timely discussions about the current and future role of nuclear cardiology and other imaging modalities
• Educational webinars: ASNC is pleased to offer an ongoing series of complimentary online webinars on various topics, in partnership with the International Atomic Energy Agency (IAEA)
• Coming soon: ASNC is constantly working to add more events and educational opportunities for nuclear cardiology professionals and technologists

JOIN NOW

Join today to receive the valuable educational benefits of membership and support a society that, like you, continually supports quality improvement and patient-centered imaging.

Siemens Biograph mCT Flow

 

 

Siemens Molecular Imaging

Biograph mCT Flow

 FlowMotion, the end of stop and go

Equipado com a tecnologia FlowMotion criada pela SIEMENS, o Biograph mCT Flow é o primeiro PET/CT do mundo a eliminar o sistema  de aquisição de imagens por bed positions. Agora, a aquisição é baseada em um movimento contínuo único da mesa do paciente.

O Biograph mCT Flow permite adquirir a melhor resolução de imagem  para cada órgão em uma varredura única, fornecendo a quantificação exata e reprodutível em todas as dimensões. Visando a menor dose de radiação possível, agilidade e conforto ao paciente.

 

Para mais informações, clique aqui!

Médico esclarece dúvidas sobre medicina nuclear

Você já ouviu falar em medicina nuclear? Trata-se de uma especialidade médica que usa quantidades mínimas de substâncias radioativas (radiofármacos) como ferramentas para se obter informações diagnósticas sem que sejam necessários exames invasivos.

Apesar de o nome poder parecer assustador – como assim, “nuclear”? – ,esse tipo de medicina proporciona inúmeros benefícios à saúde na medida em que permite diagnosticar com mais facilidade doenças como embolia pulmonar, infecções agudas e câncer.

Para explicar melhor do que se trata a medicina nuclear e esclarecer algumas dúvidas que podem ser comuns, o DTUP recebeu o médico Carlyle Barral:

Link original: http://redesuper.com.br/detudoumpouco/2014/06/26/medico-esclarece-duvidas-sobre-medicina-nuclear/

Medicina Nuclear 2014 - Prazo para Envio de Trabalhos Prorrogado!

Curso Intensivo de PET/CT (HANDS ON) em SP

Estão abertas as inscrições para o 6º Curso Intensivo de PET/CT (HANDS ON). Sob a organização da SBMN, o encontro acontece no Hotel Grand Plaza, em São Paulo, entre os dias 14 e 17 de agosto.

Direcionado para médicos com título de especialista em medicina nuclear, o curso abordará os princípios de funcionamento da PET/CT, noções de anatomia seccional e as principais aplicações do método na oncologia, sempre com uma abordagem direta e objetiva, seguida de sessões práticas de interpretações de imagens.

Os participantes terão a oportunidade de analisar casos de PET/CT em PACS Workstations rodando osoftware Osirix (dois alunos por computador). Além disso, serão apresentadas as técnicas de quantificação de lesões, reconstrução volumétrica e análise comparativa de múltiplos estudos.

As vagas são limitadas. Confira o programa e inscreva-se! http://goo.gl/g6m20T

Link original: http://www.sbmn.org.br/site/secao/visualiza/1217

Fique atento aos prazos das inscrições para o Congresso Brasileiro de Medicina Nuclear

O primeiro prazo das inscrições online com desconto para o XXVIII Congresso Brasileiro de Medicina Nuclear encerra hoje (26 de junho) e, o segundo, 26 de agosto. Após esta data, as inscrições poderão ser efetuadas apenas no dia e local do evento, que será realizado no Centro de Convenções Rebouças, em São Paulo, de 26 a 28 de setembro.

O prazo para submissão de trabalhos científicos também encerra hoje. Para que o trabalho seja aceito, um dos autores ou o apresentador deverá estar inscrito no Congresso. Portanto, assim que enviar o seu trabalho, faça sua inscrição pelo site. Acesse! http://goo.gl/8W1o6X

Link original: http://www.sbmn.org.br/site/secao/visualiza/1216

Nova edição da revista de humanidades está disponível online

Publicação está disponível na plataforma online do CFM

Está disponível na plataforma online de publicações do Conselho Federal de Medicina (CFM) a quarta edição de "Medicina CFM – Revista de humanidades médicas". Em destaque, a reportagem "O paciente, o médico e o espelho" traz uma reflexão sobre o conceito de autoimagem e as repercussões que as alterações do corpo provocam sobre o paciente e o processo de cura.

O impacto da tecnologia também é tratado em duas reportagens. Em "O delicado equilíbrio entre a arte e a técnica", discutimos se o arsenal tecnológico que avança a cada dia (inovações em exames de imagem, engenharia genética e transplantes de órgãos) estaria suprimindo o raciocínio clínico. O leitor acompanhará os debates que conduzem à seguinte reflexão: há dicotomia entre inovação e humanização? Também falamos de tecnologia quando o assunto é medicina do esporte. Na reportagem "Quando a medicina leva ao podium", tratamos das contribuições que a medicina trouxe para a prática desportiva, mostrando a parcela de sua responsabilidade na construção de resultados e campeões.

Outra frente desbravada nesta edição de Medicina CFM foi o debate realizado sobre a dura realidade do assédio sexual não só na sociedade, mas também no ambiente médico e hospitalar. Na seção Painel, experientes profissionais foram convidados a traçar o perfil desse fenômeno silencioso e infelizmente corrente.

Acesse a revista aqui. A publicação também pode ser lida diretamente na tela de dispositivos móveis, tablets e smartphones que utilizam os sistemas operacionais Android e IOS. Saiba mais sobre a ferramenta e o passo-a-passo para instalação em http://goo.gl/w8L2mM

Link original: http://www.sbmn.org.br/site/secao/visualiza/1214

XXVIII Congresso Brasileiro de Medicina Nuclear - Finaliza amanhã!